Maria Cristina Mingari
Overview
Explore the profile of Maria Cristina Mingari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
153
Citations
7769
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guevara Lopez M, Gebo A, Parodi M, Persano S, Maus-Conn J, Mingari M, et al.
J Immunother Cancer
. 2025 Feb;
13(2).
PMID: 39939140
Background: Due to their enhanced responsiveness and persistence, cytokine-induced memory-like (CIML)-natural killer (NK) cells have emerged as new immunotherapeutic tools against malignancies. However, their effects on tumor-cell spread and metastases...
2.
Cantoni C, Falco M, Vitale M, Pietra G, Munari E, Pende D, et al.
Oncoimmunology
. 2024 Jul;
13(1):2378520.
PMID: 39022338
The long story of NK cells started about 50 y ago with the first demonstration of a natural cytotoxic activity within an undefined subset of circulating leukocytes, has involved an...
3.
Garbarino O, Valenti G, Monteleone L, Pietra G, Mingari M, Benzi A, et al.
Front Oncol
. 2023 Aug;
13:1210130.
PMID: 37534247
Background: Malignant melanoma is the most lethal form of skin cancer which shows BRAF mutation in 50% of patients. In this context, the identification of BRAF mutation led to the...
4.
Sidoti Migliore G, Campana S, Barberi C, De Pasquale C, Pezzino G, Cavaliere R, et al.
J Leukoc Biol
. 2023 Feb;
113(5):535-540.
PMID: 36807710
Polyvalent mechanical bacterial lysate is effective in the prevention of respiratory tract infections, although its mechanism of action is not entirely elucidated. Because epithelial cells constitute the frontline defense against...
5.
Tumino N, Nava Lauson C, Tiberti S, Besi F, Martini S, Fiore P, et al.
Int J Cancer
. 2022 Dec;
152(8):1698-1706.
PMID: 36468179
NK cells represent key players capable of driving antitumor immune responses. However, the potent immunosuppressive activity of the tumor microenvironment (TME) may impair their effector function. Here, we strengthen the...
6.
Grottoli M, Carrega P, Zullo L, Dellepiane C, Rossi G, Parisi F, et al.
Cancers (Basel)
. 2022 Oct;
14(20).
PMID: 36291830
Immune checkpoint inhibitors (ICIs) immunotherapy has represented a breakthrough in cancer treatment. Clinical use of ICIs has shown an acceptable safety profile and promising antitumor activity. Nevertheless, some patients do...
7.
Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise?
Damele L, Spaggiari G, Parodi M, Mingari M, Vitale M, Vitale C
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139598
In the last 20 years, Natural Killer (NK) cell-based immunotherapy has become a promising approach to target various types of cancer. Indeed, NK cells play a pivotal role in the...
8.
Meazza R, Falco M, Canevali P, Loiacono F, Colomar-Carando N, Muntasell A, et al.
HLA
. 2022 Apr;
100(2):119-132.
PMID: 35439359
The phenotypic identification of different NK cell subsets allows more in-depth characterization of KIR repertoire and function, which are of potential interest in KIR and disease association studies. KIR genes...
9.
Tumino N, Besi F, Martini S, Di Pace A, Munari E, Quatrini L, et al.
Front Immunol
. 2022 Feb;
12:803014.
PMID: 35116033
Tumor microenvironment (TME) includes a wide variety of cell types and soluble factors capable of suppressing immune-responses. While the role of NK cells in TME has been analyzed, limited information...
10.
Colomar-Carando N, Gauthier L, Merli P, Loiacono F, Canevali P, Falco M, et al.
Cancer Immunol Res
. 2022 Jan;
10(3):291-302.
PMID: 35078821
Natural killer (NK) cells represent a promising cell type in antitumor immunotherapy for efficacy and safety, particularly in the treatment of hematologic malignancies. NK cells have been shown to exert...